| Name | MAFG antisense RNA 1 (head to head) |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Multiple recent studies have demonstrated that the long noncoding RNA MAFG‑AS1 is frequently overexpressed in a variety of malignancies—including colorectal, lung (adenocarcinoma and non‑small cell), breast (including estrogen receptor–positive subtypes), hepatocellular, gastric, bladder, ovarian, esophageal, pancreatic, and even brain cancers—and its aberrant expression is generally associated with advanced tumor stage, metastasis, and poor patient prognosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Functionally, MAFG‑AS1 exerts its oncogenic role primarily by acting as a competing endogenous RNA (ceRNA) that sponges various tumor‐suppressive microRNAs—such as miR‑147b in colorectal cancer; miR‑744‑5p in lung adenocarcinoma; miR‑339‑5p in non–small cell lung and breast cancers; miR‑150‑5p and miR‑574‑5p in breast cancer; miR‑125b‑5p and miR‑143‑3p in bladder cancer; miR‑149‑3p in colorectal cancer; and miR‑765 in esophageal cancer—thereby derepressing diverse oncogenic factors (including NDUFA4, MAF, MMP15, CDK2, MYB, SphK1, COX‑2, OTX1, PLK1, SERPINE1, HOXB8, and PDX1) that drive proliferation, epithelial–mesenchymal transition, invasion, migration, metabolic reprogramming, and resistance to apoptosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition, MAFG‑AS1 has been shown to modulate key signaling pathways (for instance, the JAK2/STAT3 cascade in breast cancer) and to interact with RNA‐binding proteins (such as HuR in bladder cancer) to promote the stability of oncogenic transcripts. Notably, while its overexpression promotes tumorigenesis across multiple contexts, one study also indicated that in non‐malignant periodontal ligament stem cells MAFG‑AS1 is downregulated and may influence Toll‑like receptor 4 expression via interplay with miR‑146a, suggesting that its functional impact may depend on the cellular context."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings indicate that MAFG‑AS1 acts as a central oncogenic regulator by sponging a spectrum of microRNAs and upregulating downstream effectors that control proliferation, cell cycle progression, metastasis and metabolic pathways. This multifaceted role establishes MAFG‑AS1 not only as a promising prognostic biomarker across diverse cancer types but also as a potential therapeutic target for precision oncology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "17"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Shanshan Cui, Xi Yang, Lihong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.10.112"}], "href": "https://doi.org/10.1016/j.bbrc.2018.10.112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30348529"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30348529"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yuan Sui, Guangyao Lin, Yinshi Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Pharmacol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejphar.2019.172465"}], "href": "https://doi.org/10.1016/j.ejphar.2019.172465"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31211984"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31211984"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "You Chao Jia, Jian Yi Wang, Yu Ying Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbin.11092"}], "href": "https://doi.org/10.1002/cbin.11092"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30599080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30599080"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "H Li, G-Y Zhang, C-H Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201904_17561"}], "href": "https://doi.org/10.26355/eurrev_201904_17561"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31002134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31002134"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jing Feng, Ti Wen, Zhi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.103966"}], "href": "https://doi.org/10.18632/aging.103966"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33098638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33098638"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hongyao Jia, Di Wu, Zhiru Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulatory effect of the MAFG‑AS1/miR‑150‑5p/MYB axis on the proliferation and migration of breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2020.5150"}], "href": "https://doi.org/10.3892/ijo.2020.5150"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33367930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33367930"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Chenye Tang, Yuntao Wu, Xiao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Cell (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13577-020-00470-3"}], "href": "https://doi.org/10.1007/s13577-020-00470-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33400245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33400245"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Dengbao Li, Siwen Zhong, Zhiqiang Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathobiology (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000509957"}], "href": "https://doi.org/10.1159/000509957"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33238264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33238264"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Chao Li, Rongfang Wu, Youzhong Xing "}, {"type": "b", "children": [{"type": "t", "text": "MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2020.1728017"}], "href": "https://doi.org/10.1080/15384101.2020.1728017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32079456"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32079456"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Z-Q Hu, H-C Li, F Teng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA MAFG-AS1 facilitates the progression of hepatocellular carcinoma via targeting miR-3196/OTX1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202012_24002"}], "href": "https://doi.org/10.26355/eurrev_202012_24002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33336731"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33336731"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yang Bai, Chenchen Ren, Baojin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Gene Ther (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41417-021-00306-8"}], "href": "https://doi.org/10.1038/s41417-021-00306-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34035482"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34035482"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Ji Dai, Shuangshuang Zhang, Haohang Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 affects the tumorigenesis of breast cancer cells via the miR-574-5p/SOD2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2021.04.133"}], "href": "https://doi.org/10.1016/j.bbrc.2021.04.133"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33989902"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33989902"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Kaixin Wangzhou, Lei Gong, Cheng Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 regulates human periodontal ligament stem cell proliferation and Toll-like receptor 4 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oral Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/odi.13330"}], "href": "https://doi.org/10.1111/odi.13330"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32176822"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32176822"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Liqing Ye, Weijian Feng, Hanqin Weng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12935-020-01669-y"}], "href": "https://doi.org/10.1186/s12935-020-01669-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33298078"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33298078"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Xi Sun, Yi Cai, Xiheng Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Cancer Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21037/tcr-20-1971"}], "href": "https://doi.org/10.21037/tcr-20-1971"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35117325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35117325"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Cui-Juan Qian, Zhu-Rong Xu, Lu-Yan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Manag Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/CMAR.S262075"}], "href": "https://doi.org/10.2147/CMAR.S262075"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32801913"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32801913"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Zhiyan Ruan, Hongling Deng, Minhua Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of long non-coding RNA MAFG-AS1 represses tumorigenesis of colorectal cancer cells through the microRNA-149-3p-dependent inhibition of HOXB8."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12935-020-01485-4"}], "href": "https://doi.org/10.1186/s12935-020-01485-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33093810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33093810"}]}]}]}
|
| Synonyms | MAFG-DT |
| NCBI Gene ID | 92659 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MAFG-AS1 has 2,010 functional associations with biological entities spanning 5 categories (molecular profile, organism, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 19 datasets.
Click the + buttons to view associations for MAFG-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MAFG-AS1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MAFG-AS1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAFG-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of MAFG-AS1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAFG-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MAFG-AS1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MAFG-AS1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MAFG-AS1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MAFG-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MAFG-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MAFG-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MAFG-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MAFG-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MAFG-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MAFG-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MAFG-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MAFG-AS1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MAFG-AS1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MAFG-AS1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |